Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
37.05
-0.79 (-2.09%)
At close: Sep 18, 2026, 4:00 PM EDT
37.63
+0.58 (1.57%)
After-hours: Sep 18, 2026, 7:37 PM EDT

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2692869119123359
Market Cap Growth
384.95%-59.65%-42.03%-2.89%-65.85%-5.17%
Enterprise Value
25514468183295
Last Close Price
37.059.1632.7079.2085.50339.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.151.017.4421.7098.5324.04
PB Ratio
83.871.053.953.211.875.49
P/TBV Ratio
116.511.053.953.211.875.49

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.770.504.9714.7266.7519.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.330.160.510.400.290.15
Net Debt / Equity Ratio
-6.21-0.91-0.83-0.92-0.87-0.83
Net Debt / EBITDA Ratio
0.150.940.350.661.081.28
Net Debt / FCF Ratio
0.291.100.400.851.361.37
Asset Turnover
1.060.740.200.070.010.16
Quick Ratio
1.072.641.782.966.615.28
Current Ratio
1.252.741.843.016.685.35
Return on Equity (ROE)
-1603.48%-121.11%-149.03%-98.73%-80.82%-61.16%
Return on Assets (ROA)
-172.66%-44.56%-55.47%-42.53%-38.29%-29.87%
Return on Capital Employed (ROCE)
-1039.60%-92.30%-224.80%-117.00%-67.10%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-60.97%-95.47%-58.90%-42.59%-43.21%-12.29%
FCF Yield
-18.64%-78.47%-52.71%-33.55%-34.22%-11.07%
Buyback Yield / Dilution
-84.06%-68.18%-23.11%-28.35%-13.95%-9.05%
SEC Filings: 10-K · 10-Q